• Product NameBetahistine mesylate
• Brief DescriptionInhibitors
• Purification99.00%
• Biological ActivityBetahistine is an antivertigo drug first used for treating vertigo assosicated with Mnires disease. It is also commonly used for patients with balance disorders.
• Target NameHistamine Receptor antagonist
• CAS No. 54856-23-4
• Calculated MW 328.4
• Formulation C8H12N22(CH4O3S)
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Nervous system
  SMILES:CS(O)(=O)=O.CS(O)(=O)=O.CNCCC1=CC=CC=N1
  Pathways:GPCR/G Protein; Immunology/Inflammation; Neuroscience
  Receptor:H1 receptor; H3 receptor
  Boling pt:210.9C
  Melting pt:112C
  Solubility:Soluble in DMSO
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Lacour M, Sterkers O. CNS Drugs. 2001; 15(11): 853-70.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting